For decades, contraception and the pill accessibility conversation has largely been a monologue in which women have carried much of the medical burden. The pill, implant, injection and IUD are familiar options, while men have traditionally abstained from the onus of medical procedures and hormonal tampering-with. But now, that could be changing.

A new male contraceptive pill called YCT-529 has passed an important early test in humans – and unlike previous attempts, it doesn't use hormones.

How does a male contraceptive pill work?

This particular drug – YCT-529 – interferes with a vitamin A-related pathway, signalling that sperm-producing cells need to get the manufacturing process started. More specifically, it blocks a vitamin A metabolite from binding to a receptor called RAR-alpha, disrupting the gene activity required for sperm production.

The idea is surprisingly simple: temporarily switch off the sperm factory rather than altering testosterone levels throughout the body.

Does “safe” mean it actually prevents pregnancy?

Not yet – and this is probably the most important bit to understand.

The first human trial involved a mere 16 healthy men, all of whom had already undergone vasectomies. The researchers were primarily asking whether YCT-529 was tolerated by the body and how the drug behaved in the bloodstream.

The study, published in Communications Medicine, did not test whether the pill successfully lowered sperm counts enough to prevent pregnancy. So “safe in an early trial” in this case is very different from being officially a “proven contraceptive.”

Also, the male body takes roughly three months to produce mature sperm, meaning a future male contraceptive targeting sperm production would probably need to be taken for several months before reaching full effectiveness. And once someone stopped taking it, sperm production would also be expected to take time to recover.

When could it be available?

The World Health Organization's latest update says several hormonal and non-hormonal male contraceptives are now in advanced clinical development, with some potentially reaching the market within the next 5–10 years.

Are men actually interested?

Apparently, yes. Research cited by WHO found that more than 75% of surveyed couples said they would be willing to use a new male contraceptive, while more than 85% of women surveyed said they would trust their male partners to take responsibility for contraception.

That helps explain why the idea is attracting attention – including in Australia, where 7NEWS found generally positive reactions when it asked people on Sydney streets about the prospect.